Log in
Enquire now
MobileODT

MobileODT

MobileODT is an Israel-based developer of connected visual diagnostic tools for cancer detection through smartphones.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
AngelList URL
angel.co/mobileodt
B2X
B2B
B2B
0
CEO
Ariel Beery
Ariel Beery
Company Operating Status
Active
Country
Israel
Israel
Crunchbase URL
crunchbase.com/organiz...obileoct
CTO
‌
David Levitz
Email Address
info@mobileodt.com
Facebook URL
@MobileODT
Founded Date
2017
0
Founder
‌
David Levitz
Ariel Beery
Ariel Beery
Headquarters
Tel Aviv
Tel Aviv
Industry
Medical imaging
Medical imaging
‌
Deep Tech
Diagnostic tools
Diagnostic tools
Medical device
Medical device
Medical equipment
Medical equipment
Women's Health
Women's Health
Solution Analysts
Solution Analysts
Femtech
Femtech
Health technology
Health technology
Diagnosis
Diagnosis
•••
Instagram URL
instagram.com/mobileodt/
Investors
Tristel plc
Tristel plc
Laerdal Million Lives Fund
Laerdal Million Lives Fund
OrbiMed
OrbiMed
Latest Funding Round Date
August 12, 2020
Latest Funding Type
Series C
Series C
LinkedIn URL
@company/mobileodt
Location
Tel Aviv
Tel Aviv
Israel
Israel
Number of Employees (Ranges)
11 – 50
0
Patents Assigned (Count)
3
Phone Number
+16694059288
+19293760061
Pitchbook URL
pitchbook.com/profiles.../93460-96
Total Funding Amount (USD)
10,825,000
Twitter URL
@MobileODT
Official Website
mobileodt.com
Wellfound ID
mobileodt

Find more companies like MobileODT

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.